Jennison Associates’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,811
| Closed | -$539K | – | 620 |
|
|
2025
Q1 | $539K | Buy |
60,811
+1,796
| +3% | +$15.9K | ﹤0.01% | 547 |
|
|
2024
Q4 | $809K | Buy |
59,015
+34,853
| +144% | +$478K | ﹤0.01% | 510 |
|
|
2024
Q3 | $662K | Buy |
+24,162
| New | +$662K | ﹤0.01% | 531 |
|
|
2019
Q1 | – | Sell |
-16,388
| Closed | -$476K | – | 673 |
|
|
2018
Q4 | $476K | Sell |
16,388
-1,069
| -6% | -$31.1K | ﹤0.01% | 619 |
|
|
2018
Q3 | $803K | Sell |
17,457
-11,147
| -39% | -$513K | ﹤0.01% | 569 |
|
|
2018
Q2 | $1.07M | Buy |
28,604
+613
| +2% | +$22.9K | ﹤0.01% | 563 |
|
|
2018
Q1 | $827K | Buy |
+27,991
| New | +$827K | ﹤0.01% | 568 |
|